NCT03444064View on ClinicalTrials.gov

PolyTreg Immunotherapy in Islet Transplantation

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

August 12, 2024

Study Completion Date

December 17, 2024

Conditions
DiabetesDiabetes Mellitus, Type 1
Interventions
BIOLOGICAL

PolyTregs

Treatment group receive PolyTregs 6 weeks after islet transplantation as immunotherapy to improve islet survival and reduce the need for immunosuppression drugs.

Trial Locations (1)

T6G 2C8

University of Alberta, Edmonton

Sponsors
All Listed Sponsors
collaborator

Diabetes Research Institute Foundation

OTHER

collaborator

Liana's Dream Foundation

UNKNOWN

collaborator

Juvenile Diabetes Research Foundation

OTHER

collaborator

Alberta Diabetes Institute

OTHER

lead

University of Alberta

OTHER